What is HC Wainwright’s Forecast for SENS FY2026 Earnings?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) – Equities researchers at HC Wainwright raised their FY2026 earnings per share estimates for shares of Senseonics Holdings, Inc. Common Stock in a research note issued on Tuesday, November 10th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings of ($2.35) per share for the year, up from their previous forecast of ($2.41). HC Wainwright has a “Buy” rating and a $14.00 price objective on the stock. The consensus estimate for Senseonics Holdings, Inc. Common Stock’s current full-year earnings is ($2.31) per share. HC Wainwright also issued estimates for Senseonics Holdings, Inc. Common Stock’s Q4 2026 earnings at ($0.54) EPS, Q1 2027 earnings at ($0.64) EPS, Q2 2027 earnings at ($0.59) EPS, Q3 2027 earnings at ($0.47) EPS, Q4 2027 earnings at ($0.41) EPS, FY2027 earnings at ($2.13) EPS, FY2028 earnings at ($1.56) EPS, FY2029 earnings at ($1.04) EPS and FY2030 earnings at ($0.48) EPS.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings results on Monday, November 9th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). The company had revenue of $19.56 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 186.11% and a negative net margin of 204.01%.

A number of other research firms also recently weighed in on SENS. Stifel Nicolaus reaffirmed a “hold” rating and set a $10.00 price target (up from $9.00) on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday. TD Cowen lifted their target price on Senseonics Holdings, Inc. Common Stock from $15.00 to $17.00 and gave the stock a “buy” rating in a research report on Tuesday. Raymond James Financial upgraded Senseonics Holdings, Inc. Common Stock from an “underperform” rating to a “market perform” rating in a research report on Tuesday. Barclays increased their price objective on shares of Senseonics Holdings, Inc. Common Stock from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Tuesday. Finally, Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Three analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $14.40.

Senseonics Holdings, Inc. Common Stock Stock Up 3.9%

Senseonics Holdings, Inc. Common Stock stock opened at $10.42 on Thursday. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $13.98. The company has a debt-to-equity ratio of 0.70, a quick ratio of 6.40 and a current ratio of 5.92. The firm has a market cap of $435.59 million, a PE ratio of -4.53 and a beta of 1.04. The firm’s 50 day moving average price is $9.16 and its two-hundred day moving average price is $7.29.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE bought a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth about $2,241,000. BlackRock Inc. bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at $15,867,000. Masters Capital Management LLC increased its stake in shares of Senseonics Holdings, Inc. Common Stock by 100.0% during the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock worth $3,330,000 after purchasing an additional 250,002 shares during the last quarter. Readystate Asset Management LP bought a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $574,000. Finally, Penn Capital Management Company LLC bought a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth $535,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

Insiders Place Their Bets

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder bought 13,953 shares of the firm’s stock in a transaction on Wednesday, August 19th. The stock was purchased at an average cost of $8.98 per share, with a total value of $125,297.94. Following the completion of the purchase, the director owned 171,191 shares in the company, valued at approximately $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 4.70% of the company’s stock.

Key Headlines Impacting Senseonics Holdings, Inc. Common Stock

Investors following SENS have been watching these headlines:

• Positive Sentiment: Senseonics’ fiscal 2026 revenue guidance of $68 million–$70 million came in above the $64.2 million consensus estimate, a potentially favorable signal for sales expectations.
• Positive Sentiment: The shares reached a new one-year high following an analyst upgrade, reflecting recent investor demand and positive coverage. Shares reach one-year high
• Neutral Sentiment: Other analysts were more measured: Barclays raised its target to $11 but kept Equal Weight, Stifel raised its target to $10 and maintained Hold, and Raymond James moved its rating to Market Perform. Stifel rating Barclays coverage Raymond James rating

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.